The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
domantis | 493 |
bristol-myers squibb company | 124 |
glaxo group | 22 |
lipotek | 12 |
cephalon australia | 7 |
arana therapeutics | 3 |
peptech | 3 |
argenta discovery | 3 |
argenta diskaveri | 1 |
lipotek pty ltd of | 1 |
domantis | 84 |
glaxo group | 4 |
arana therapeutics | 2 |
peptech | 2 |
argenta discovery | 1 |
domantis | 21 |
bristol-myers squibb company | 19 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
polypeptides, antibody variable domains and antagonists | 110 | 2007 |
compositions monovalent for cd28 binding and methods of use | 53 | 2008 |
antibody polypeptides that antagonize cd40 | 49 | 2011 |
antibody polypeptides that antagonize cd40l | 40 | 2011 |
monovalent anti-cd40l antibody polypeptides and compositions thereof | 24 | 2004 |
antibody single variable domains against serum albumin | 21 | 2002 |
plad domain peptides with increased serum half life due to conjugation to domain antibod… 🛈 | 20 | 2004 |
polypeptides, antibody variable domains & antagonists | 18 | 2007 |
method to screen phage display libraries with different ligands | 17 | 1997 |
agents that bind a target in pulmonary tissue for treating respiratory diseases | 17 | 2005 |